UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~October~~January 31, ~~2025~~2026

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number ~~333~~: 000-~~268561~~56822

MAG MAGNA CORP.

(Exact name of registrant as specified in its charter)

wyoming

98-1626237

2810

(State or Other Jurisdiction of Incorporation or Organization)

(I.R.S. Employer

Identification Number)

(Primary Standard Industrial Classification Code Number)

4005 West Reno Avenue, Suite F

Las Vegas, Nevada 89118

702-595-2247

(Address, including Zip Code, and Telephone Number, ~~including Area Code, of Registrant's Principal Executive Office)~~

Securities registered under Section 12(b) of the Exchange Act:
Title of each class	Trading Symbol	Name of each exchange on which registered
N/A	N/A	N/A
Securities registered under Section 12(g) of the Exchange Act:
None

including Area Code, of Registrant's Principal Executive Office)

Securities registered under Section 12(b) of the Exchange Act:

Title of each class

Trading Symbol

Name of each exchange

on which registered

N/A

Securities registered under Section 12(g) of the Exchange Act:

Common Stock, $0.001 par value

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐ ☒ No ☒☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated Filer	☐	Accelerated Filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

State the number of shares outstanding of ~~each~~ each of the issuer's classes of common equity, as of the latest practicable date: 515,~~829~~529,047 common shares issued and outstanding as of ~~January~~March 2726, 2026.

TABLE OF CONTENTS

		Page
PART I	FINANCIAL INFORMATION:
Item 1.	Condensed Financial Statements (Unaudited)	3
	Condensed Balance Sheets as of October 31, 2025 (Unaudited) and April 30, 2024	4
	Condensed Balance Sheets as of January 31, 2026 (Unaudited) and April 30, 2025	4
	Condensed Statements of Operations for the three and six months ended October 31, 2025 and 2024 (Unaudited)	5
	Condensed Statements of Operations for the Three and Nine Months Ended January 31, 2026 and 2025 (Unaudited)	5
	Condensed Statements of Changes in Stockholders’ Equity (Deficit) for the Six Months ended October 31, 2025 and 2024 (Unaudited)	6
	Condensed Statements of Changes in Stockholders’ Equity (Deficit) for the Nine Months ended January 31, 2026 and 2025 (Unaudited)	6
	Condensed Statements of Cash Flows for the Six Months Ended October 31, 2025 and 2024 (Unaudited)	7
	Condensed Statements of Cash Flows for the Nine Months Ended January 31, 2026 and 2025 (Unaudited)	7
	Notes to the Condensed Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1617
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	18
Item 4.	Controls and Procedures	1819
PART II	OTHER INFORMATION:
Item 1.	Legal Proceedings	1920
Item 1A.	Risk Factors	1920
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	1920
Item 3.	Defaults Upon Senior Securities	1920
Item 4.	Mine Safety Disclosures	1920
Item 5.	Other Information	1920
Item 6.	Exhibits	2021
Signatures		2122

PART I - FINANCIAL INFORMATION

Item 1. Condensed Financial Statements.

The accompanying interim condensed financial statements of Mag Magna Corp. (the “Company,” “we,” “us,” or “our”), have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with United States generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations.

The interim financial statements are condensed and should be read in conjunction with the Company’s latest annual financial statements.

In the opinion of management, the condensed financial statements contain all material adjustments, consisting only of normal recurring adjustments, considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

MAG MAGNA CORP

~~Condensed~~CONDENSED ~~Balance~~BALANCE ~~Sheets~~SHEETS

As of October 31, 2025 and April 30, 2025


	As of January 31, 2026 (Unaudited)			As of April 30, 2025 (Audited)

ASSETS
Current Assets
Cash	$	26,400		$	–
Prepaid Expense		–			25,975
Total Current Assets		26,400			25,975
Other Assets
Mining assets		1,900,000			–
Intangible Assets, net		–			118,322
Total Other Assets		1,900,000			118,322
TOTAL ASSETS	$	1,926,400		$	144,297

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Liabilities
Current Liabilities
Accounts Payable	$	5,668		$	396
Deferred Income		–			5,272
Acquisition payable		300,000			–
Loan Payable – Related Parties		195,869			221,927
Total Current Liabilities		501,537			227,595
Total Liabilities		501,537			227,595
Stockholders’ Equity (Deficit)
Common stock, $0.001 par value, 500,000,000 shares authorized, 7,829,047 and 5,829,047 shares issued and outstanding at January 31, 2026 and April 30, 2025, respectively		7,829			5,829
Additional Paid-in Capital		1,766,897			31,897
Accumulated Deficit		(349,863	)		(121,024	)
Total Stockholders’ Equity / (Deficit)		1,424,863			(83,298	)
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY (DEFICIT)	$	1,926,400		$	144,297

	As of October 31, 2025 (Unaudited)			As of April 30, 2025 (Audited)
ASSETS
Current Assets
Prepaid Expense	$	9,345		$	25,975
Total Current Assets		9,345			25,975
Other Assets
Intangible Assets, net		103,745			118,322
Total Other Assets		103,745			118,322
TOTAL ASSETS	$	113,090		$	144,297
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Liabilities
Current Liabilities
Accounts Payable	$	5,668		$	396
Deferred Income		–			5,272
Loan Payable – Related Party		151,434			221,927
Total Current Liabilities		157,102			227,595
Total Liabilities		157,102			227,595
Stockholders’ Equity (Deficit)
Common stock, $0.001 par value, 75,000,000 shares authorized, 5,829,047 and 5,829,047 shares issued and outstanding at October 31, 2025 and April 30, 2025, respectively		5,829			5,829
Additional Paid-in Capital		168,897			31,897
Accumulated Deficit		(218,738	)		(121,024	)
Total Stockholders’ Equity (Deficit)		(44,012	)		(83,298	)
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY (DEFICIT)	$	113,090		$	144,297

The accompanying notes are an integral part of the condensed financial statements.

MAG MAGNA CORP

~~Condensed~~CONDENSED ~~Statements~~STATEMENTS ofOF ~~Operations~~OPERATIONS

For the three and six months ended October 31, 2025 and 2024

(Unaudited)

Three months ended October 31, 2025

Three months ended October 31, 2024

Six months ended October 31, 2025

Six months ended October 31, 2024

Three months Ended January 31, 2026

Three Months Ended January 31, 2025

Nine Months Ended January 31, 2026

Nine Months Ended January 31, 2025

Revenues:

Consulting services

–

9,~~339~~987

–

1323,~~739~~726

API Requests

–

612,~~702~~307

–

719,~~595~~902

TOTAL REVENUE

–

1622,~~041~~294

–

2143,~~334~~628

OPERATING EXPENSES

General and administrative expenses

7131,~~288~~125

2726,~~075~~964

97228,~~714~~839

4673,~~396~~360

TOTAL OPERATING EXPENSES

7131,~~288~~125

2726,~~075~~964

97228,~~714~~839

4673,~~396~~360

INCOME (LOSS) FROM OPERATIONS

(7131,~~288~~125

)

(114,~~034~~670

)

(97228,~~714~~839

)

(2529,~~062~~732

)

OTHER INCOME (EXPENSE)

Interest income

–

TOTAL OTHER INCOME (EXPENSE)

–

NET INCOME (LOSS)

(7131,~~288~~125

)

(114,~~034~~670

)

(97228,~~714~~839

)

(2529,~~060~~730

)

NET INCOME (LOSS) PER SHARE

(0.0002

)

(0.00

)

(0.0004

)

(0.0001

)

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED

56,~~829~~089,~~047~~917

5,829,047

5,~~829~~916,~~047~~004

5,829,047

The accompanying notes are an integral part of the condensed financial statements.

MAG MAGNA CORP

~~Condensed~~CONDENSED ~~Statements~~STATEMENTS ofOF ~~Changes~~CHANGES inIN ~~Stockholders~~SHAREHOLDERS’ ~~Equity~~EQUITY (~~Deficit~~DEFICIT)

For the ~~six~~Three ~~months~~and ~~ended~~Nine ~~October~~Months Ended January 31, ~~2025~~2026 and ~~2024~~ 2025

(Unaudited)

					Additional					Total
	Common Stock				Additional Paid-In Capital		Accumulated Deficit			Total Stockholders’ Equity (Deficit)
	Common Stock				Paid-in		Accumulated			Stockholders’
	Shares		Amount ($)		($)		($)			($)
	Shares		Amount		Capital		Deficit			Equity (Deficit)
Balance April 30, 2025		5,829,047		5,829		31,897		(121,024	)		(83,298	)
Balance at April 30, 2024		5,829,047	$	5,829	$	31,897	$	(68,770	)	$	(31,044	)
Gain on forgiveness of debt – related party		–		–		137,000		–			137,000
Net loss		–		–		–		(2590,~~060~~425	)		(2590,~~060~~425	)
Balance at October 31, 2024		5,829,047	$	5,829	$	31,897	$	(93,830	)	$	(56,104	)
Balance July 31, 2025		–		–		168,897		(211,449	)		(36,723	)
Balance at April 30, 2025		5,829,047	$	5,829	$	31,897	$	(121,024	)	$	(83,298	)
Net loss		–		–		–		(7,289	)		(7,289	)
Related-party loan forgiveness		–		–		137,000		–			137,000
Balance October 31, 2025		5,829,047		5,829		168,897		(218,738	)		(44,012	)
Net loss		–		–		–		(97,714	)		(97,714	)
Shares issued for acquisition of mining assets		2,000,000		2,000		1,598,000		–			1,600,000
Balance at October 31, 2025		5,829,047	$	5,829	$	168,897	$	(218,738	)	$	(44,012	)
Net loss		–		–		–		(131,125	)		(131,125	)
Balance January 31, 2026		7,829,047		7,829		1,766,897		(349,863	)		1,424,863

	Common Stock				Additional Paid-In Capital		Accumulated Deficit			Total Stockholders’ Equity (Deficit)
	Shares		Amount ($)		($)		($)			($)
Balance April 30, 2024		5,829,047		5,829		31,897		(68,770	)		(31,044	)

Net loss		–		–		–		(14,026	)		(14,026	)
Balance July 31, 2024		–		–		31,897		(82,796	)		(45,070	)

Net loss		–		–		–		(11,034	)		(11,034	)
Balance October 31, 2024		5,829,047		5,829		31,897		(93,830	)		(56,104	)

Net loss		–		–		–		(4,670	)		(4,670	)
Balance January 31, 2025		5,829,047		5,829		31,897		(98,500	)		(60,774	)

The accompanying notes are an integral part of the condensed financial statements.

MAG MAGNA CORP

~~Condensed~~CONDENSED ~~Statements~~STATEMENTS ofOF ~~Cash~~CASH ~~Flows~~FLOWS

For the six months ended October 31, 2025 and 2024

(Unaudited)

	Six months ended October 31, 2025			Six months ended October 31, 2024
	Nine Months Ended January 31, 2026			Nine Months Ended January 31, 2025
OPERATING ACTIVITIES:
Net income	$	(97228,~~714~~839	)	$	(2529,~~060~~730	)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization expense		–14,577			611,~~875~~412
Impairment of intangibles		103,745			–
Changes in operating assets and liabilities:
Prepaid expense		1625,~~630~~975			(612,~~446~~700	)
Accounts payable		5,272			(2011,~~275~~749	)
Deferred Income		(5,272	)		1911,~~040~~549
NET CASH USED IN OPERATING ACTIVITIES		(8184,~~084~~542	)		(2531,~~866~~218	)
INVESTING ACTIVITIES:
Intangible Assets		~~14,577~~–			–
NET CASH USED IN INVESTING ACTIVITIES		~~14,577~~–			–
FINANCING ACTIVITIES:
Proceeds from borrowings – related party		–110,942			–85,347
Repayments to related party		~~(70,493~~–	)		71(54,~~202~~129	)
Additional Paid in Capital		137,000			(37,279	)
NET CASH PROVIDED BY FINANCING ACTIVITIES		110,942			31,218
NET CASH PROVIDED BY FINANCING ACTIVITIES		66,507			33,923
Net increase (decrease) in cash		26,400			–
Net increase (decrease) in cash		–			8,057
Cash at beginning of period		–			–
Cash at end of period	$	–26,400		$	~~8,057~~–
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash payments for:
Interest paid	$	–		$	–
Income taxes paid	$	–		$	–
Non-cash investing and financing activities:
Reclassification of Prepaid Expense to Intangible Assets	$	–		$	66,100
Acquisition of mining assets	$	1,900,000		$	–
Gain on forgiveness of debt – related party	$	137,000		$	–

The accompanying notes are an integral part of the condensed financial statements.

MAG MAGNA CORP

~~Notes~~NOTES toTO ~~the~~THE ~~Condensed~~UNAUDITED ~~Financial~~CONDENSED ~~Statements~~FINANCIAL STATEMENTS

~~October~~January 31, ~~2025 and 2024~~2026

~~(Unaudited)~~NOTE 1 – ORGANIZATION AND BUSINESS

1. THE COMPANY AND BASIS OF PRESENTATION

Mag Magna Corp (“the Company”) was incorporated under the laws of the State of Wyoming on September 20, 2021 (Incorporation). Until January 2026, the Company's primary focus lies in assisting and consulting businesses engaged in poultry farming.

Effective December 24, 2025, there occurred a change in control of the Company. On such date, Harpreet Sangha acquired 4,500,000 shares of the Company’s common stock from the Company’s former control person, and was appointed the Sole Officer and Director of the Company.

In January 2026, the Board of Directors determined to change the Company’s plan of business tofrom consulting within the poultry farming industry to acquiring real property rights for the mining and sale of rare earth minerals. To such end, in January 2026, the Company entered into a purchase agreement relating to certain mineral rights in and to 21 parcels of real property located in Hardin County, Illinois, and three unpatented lode mining claims located in Mohave County, Arizona.

The Company has elected April 30th as its fiscal year-end.

NOTE 2. – GOING CONCERN

Our financial statements have been prepared on on a going concern basis, which assumes that we will be able to realize our assets and discharge our liabilities and commitments in the normal course of business for the foreseeable future. We have an accumulated deficit of $~~218~~349,~~738 at~~863 as ~~October~~of January 31, ~~2025~~2026, ~~had~~ a net loss of $97228,~~714,~~839 for the and used net cash of $8184,~~084~~ 542 in operating activities for the ~~six~~nine months ended ~~October~~January 31, ~~2025~~2026. These factors raise substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern is dependent upon generating profitable operations in the future and/or to obtain the necessary financing to meet our obligations and repay our liabilities arising from normal ~~business~~ business operations when they come due. Our management intends to finance operating costs over the next twelve months with existing cash on on hand and public issuance of common stock. While we believe that we will be successful in obtaining the necessary financing and ~~generating~~ generating revenue to fund our operations, meet regulatory requirements, and achieve commercial goals, there are no assurances that such additional funding will be achieved and that we will succeed in our future operations.

NOTE 3. – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The Company uses the accrual basis of accounting and accounting principles. The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Financial Statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).

The results for the ~~three~~nine months ended ~~October~~January 31, ~~2025~~2026, are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2025, filed with the Securities and Exchange Commission.

Revenue

The Company ~~recognizes~~records ~~revenue~~transactions in accordance ~~with~~ ~~Accounting~~with ~~Standards~~ASU ~~Codification (“ASC”) 606~~2014-09, “Revenue from Contracts with Customers”. ~~The~~and ~~core~~all ~~principle~~subsequent ~~of ASC~~amendments to the ASU (collectively, “ASC 606”). isIn ~~that~~accordance anwith ~~entity~~ASC ~~recognizes~~606, ~~revenue~~revenues toare ~~depict~~recognized ~~the~~when ~~transfer~~control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration towe ~~which~~expect ~~the entity expects~~ to be entitled to in exchange for those goods or services.

An entity recognizes revenue in accordance with that core principle by applying the following steps: Step 1: Identify the contract with the customer. Step 2: Identify the performance obligations in the contract. Step 3: Determine the transaction price. Step 4. Allocate the transaction price. Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.

The revenue for our Poultry Farming Consultancy and API requests is acknowledged at a specific moment when the consulting services are completed and delivered in accordance with contractual terms. The company assumes no responsibility for any inability to fulfill obligations arising from circumstances beyond reasonable control. We may request deposits from clients before delivering services upon order placement. If deposits are obtained before providing services, the company acknowledges deferred revenue until the service delivery is completed. Payment is typically received prior to the service delivery. During the three months ended ~~October~~January 31, ~~2025~~2026, we have generated revenue from the sale of Poultry Farming Consultancy in the amount of $~~NIL~~ 0 and revenue from the sale of API requests in the amount of $~~NIL~~0. The deferred income was $~~NIL~~ 0 as of ~~October~~January 31, ~~2025~~2026.

Use of Estimates

The preparation of consolidated financial statements in conformity with ~~accounting~~GAAP ~~principles generally accepted in the United States of America~~ requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Receivables

Receivables are carried at net realizable value, representing the outstanding balance less an allowance for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual receivables, and receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received. We had an allowance for doubtful accounts of $0 as of ~~October~~January 31, ~~2025~~2026 and April 30, 2025.

Foreign Currency

The Company’s functional and reporting currency is the U.S. dollar. Transactions may occur in foreign currencies, and management has adopted ASC 830, “Foreign Currency Translation Matters”. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency-denominated transactions or balances are included in the statement.

Intangible Asset

The Company accounts for its intangible assets in accordance with ASC Subtopic 350-40, “Internal-Use Software-Computer Software Developed or Obtained for Internal Use”, and ASC Subtopic 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets”. ASC Subtopic 350-40 requires assets to be recorded at the cost to develop the asset and requires an intangible asset to be amortized over its useful life and for the useful life to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life.

Intangible assets were made up of the following at each balance sheet date:

Schedule of intangible assets
	Estimated Useful Life (years)	~~October~~January 31, ~~2025~~2026			April 30, 2025
API	5	$	121,100		$	121,100
Website	3	$	9,400		$	9,400
Software	5		9,000			9,000
			139,500			139,500
Accumulated amortization			(35,755	)		(21,178	)
Impairment			(103,745	)		–
Net book value		$	103,745		$	118,322

During the three and nine months ended ~~October~~ January 31, ~~2025 and April 30~~2026, ~~2024,~~ we recognized $~~7,288~~0 and $14,~~760~~755 in amortization expense, respectively.

The Company expects to recognize amortization expense for the capitalized website development and software costs of future years as follows:

Schedule of amortization expense
For the fiscal year ending:	Amortization Expense
April 30, 2026	$16,958
April 30, 2027	$15,020
April 30, 2028	$15,020
April 30, 2029	$14,120
April 30, 2030	$2,203

Impairment of Long-Lived Assets

The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.

Cash and Cash Equivalents

The Company considers all highly liquid investments with remaining maturities at the date of purchase of three months or less to be cash equivalents.

~~Fair Value of~~ Financial Instruments

ASC 820, “Fair Value Measurements and Disclosures,” defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a ~~three-tier~~ fair value hierarchy, ~~which~~that ~~prioritizes~~distinguishes ~~the~~between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) inand ~~measuring~~(2) ~~fair~~an ~~value.~~entity’s ~~The~~own ~~hierarchy~~assumptions ~~prioritizes~~about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy ~~into~~consists of three broad levels, ~~based~~which ongives the ~~extent~~highest priority to ~~which~~unadjusted ~~inputs~~quoted ~~used~~prices in ~~measuring~~active ~~fair~~markets ~~value~~for ~~are~~identical ~~observable~~assets inor liabilities (Level 1) and the ~~market~~lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

These tiers include:

Level 1: defined as observable inputs such as quoted prices in active markets;

Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and

Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

	Level 1 -	Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

	Level 2 -	Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

	Level 3 -	Inputs that are both significant to the fair value measurement and unobservable.

Financial instruments consist of the Company’s current assets, accounts payable and amounts due to a related party. The recorded values of all financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.

Basic and Diluted Loss Per Share

The Company computes earnings (loss) per share in accordance with ASC 260-10-45 “Earnings per Share”, which requires the presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic earnings (loss) per share is computed by dividing net earnings (loss) available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive earnings (loss) per share excludes all potential common shares if their effect is anti-dilutive. The Company has no potential dilutive instruments, and therefore, basic and diluted earnings (loss) per share are equal.

Income Taxes

The Company accounts for income taxes under the asset and liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which the differences are expected to affect taxable income. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.

Segment Reporting

The Company operates as a single operating and reportable segment, developing and deploying digital avatars. Our Chief Executive Officer is our Chief Operating Decision Maker, (“CODM”) who evaluates performance and makes operating decisions about allocating resources considering our single geographical area and on a consolidated basis. Accordingly, the CODM considers the revenue and operating expenses of our single operating segment as reported on the statement of operations and considers our current and total assets as recorded on the balance sheet. There are no additional expense or asset information that are supplemental to those disclosed in these financial statements that are regularly provided to the CODM.

Recent Accounting Pronouncements

~~The~~We ~~Company~~have ~~reviews~~reviewed ~~new~~the ~~accounting~~FASB ~~standards~~issued asASU accounting ~~issued~~pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. ~~Management~~The Company has ~~not~~carefully ~~identified~~considered ~~any~~the new ~~standards~~pronouncements that italter ~~believes~~previous generally accepted accounting principles and does not believe that any new or modified principles will have a ~~significant~~material impact on the ~~Company~~corporation’s reported financial position or operations in the ~~statements~~near term.

NOTE 4. – RELATED PARTY TRANSACTIONS

~~There have been no related party transactions for the three months ending October 31, 2025.~~ During the three months ended July 31, 2025, the former CEO and Director of the Company, Oleg Bilinski, advanced $14,351 and was repaid $6,816. Effective June 4, 2025, in conjunction with a change in control of the Company, Oleg Bilinski forgave $137,000 in related party loans owed to him by the Company. As a result, at July 31, 2025, the Company’s balance owed to Mr. Bilinski was $92,462.

During the three months ended July 31, 2025, a shareholder advanced $58,972 on behalf of the Company. The balance owed this shareholder was $58,972 as of July 31, 2025.

5During the three months ended January 31, 2026, related parties advanced the Company a total of $44,435 to cover operating expenses. ~~STOCKHOLDERS’~~ ~~EQUITY~~These advances have no written agreements, are non-interest bearing and due upon demand.

Upon formation, the total number of shares of all classes of stock which the Company is authorized to issue is Seventy-Five Million (75,000,000) shares of Common Stock, par value of $0.001 per share.

During the three months ended July 31, 2025, the former CEO and Director of the Company, Oleg Bilinski, forgave $137,000 of his related party loan which increased additional paid-in capital by $137,000.

There were 5,829,047 shares of common stock issued and outstanding as of October 31, 2025, and April 30, 2025, respectively.

6. COMMITMENTS AND CONTINGENCIES

During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with Financial Accounting Standards Board (“FASB”) ASC 450-20-50, “Contingencies”. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. As of October 31, 2025, the Company is not aware of any contingent liabilities that should be reflected in the consolidated financial statements.

~~7. CHANGE~~NOTE IN5 ~~CONTROL~~– STOCKHOLDERS’ EQUITY

OnPreferred June 4, 2025, there occurred a change in control of the Company. On such date, pursuant to a stock purchase agreement (the “Change-in-Control Agreement”), Wang Gang acquired 4,500,000 shares of the Company’s common stock (the “Control Shares”) from Oleg Bilinski. The Control Shares represent approximately 77.20% of the outstanding shares of the Company’s common stock and constitute voting control of the Company. The total consideration paid by Mr. Wang for the Control Shares was $564,380.50 in cash. Additionally, effective June 4, 2025, Mr. Wang acquired an additional 142,372 shares of the Company’s common stock from 18 Company shareholders for a total of $17,846.50 in cash, pursuant to separate stock purchase agreements.Stock

InThe ~~conjunction~~Company ~~with~~has ~~the Change-in-Control Agreements~~1, ~~on June 4~~000,000 ~~2025,~~authorized ~~Oleg~~shares ~~Bilinki resigned as President, Chief Executive Officer, Treasurer, Secretary and Director~~ of ~~the Company, Tomasz~~ ~~Anczok~~preferred ~~resigned~~stock aswith a ~~Director~~par value of ~~the~~$0.001 ~~Company~~per ~~and~~share, ~~Wang~~of ~~Gang~~which ~~was~~one ~~appointed~~(1) asshare ~~the~~has ~~Sole~~been ~~Director,~~designated ~~President,~~Series ~~Chief~~X ~~Executive~~Preferred ~~Officer,~~Stock ~~Treasurer~~(the “Series ~~and~~X ~~Secretary~~Preferred ~~of the Company~~Stock”).

8In January 2026, the Company issued one (1) share of the Series X Preferred Stock to Harpreet Sangha, its sole officer and director and holder of the majority voting power. ~~SUBSEQUENT~~ ~~EVENTS~~While Mr. Sangha held the majority voting power of the Company prior to such issuance, the Board of Directors of the Company deemed it to be in the best interests of the Company and its shareholders to assure stability and continuity during the Company’s initial stages of development to issue the Series X Share to Mr. Sangha.

InCommon accordance with ASC 855, “Subsequent Events”, the Company has analyzed its operations subsequent to October 31, 2025, and has determined that it does not have any material subsequent events to disclose in these financial statements other than the event listed below.Stock

~~Change~~The Company has 500,000,000 authorized shares of common stock with a par value of $0.001 per share. Each common share entitles the holder to one vote, in ~~Control~~person or proxy, on any matter on which action of the stockholders of the corporation is sought.

~~Effective~~During ~~December 24, 2025, there occurred a change in control of~~ the ~~Company.~~three Onmonths ~~such~~ended ~~date,~~July ~~pursuant to a stock purchase agreement (the “Change-in-Control Agreement”)~~31, ~~Harpreet~~ ~~Sangha acquired 4~~2025,~~500,000~~ ~~shares of~~ the ~~Company’s common stock (the “Control Shares”) from~~ ~~Wang Gang, the Company’s~~ former ~~control~~CEO ~~person. The Control Shares represent approximately 77.20% of the outstanding shares of the Company’s common stock~~ and ~~constitute~~Director ~~voting control~~ of the Company~~. The total consideration paid by Mr. Sangha for the Control Shares was $415~~,~~000.00,~~ ~~paid~~Oleg ~~$240~~Bilinski,~~000~~ byforgave ~~delivery of cash at the closing and~~ $~~175~~137,000~~.00~~ ~~by delivery~~ of ahis ~~secured~~related ~~promissory~~party ~~note~~loan atwhich ~~the closing,~~increased ~~with~~additional ~~such~~paid-in ~~note due and payable on or before the sixtieth day immediately following the closing date and secured~~ capital by ~~a pledge of the Control Shares in favor of Mr~~$137,000. ~~Wang.~~

InDuring ~~conjunction with~~ the ~~Change-in-Control~~three ~~Agreement, on~~months ~~December~~ended 24January 31, ~~2025~~2026, the ~~Wang~~Company ~~Gang~~issued ~~resigned as President~~2,000,000 ~~Chief~~shares ~~Executive~~of ~~Officer,~~common ~~Treasurer,~~stock ~~Secretary~~for ~~and~~the ~~Director~~acquisition of ~~the~~mining ~~Company~~rights. ~~and~~The ~~Harpreet Sangha~~shares ~~was~~were ~~appointed~~valued asusing the ~~Sole~~closing ~~Director,~~stock price ~~President,~~on ~~Chief~~the ~~Executive~~date ~~Officer,~~of ~~Treasurer~~agreement ~~and~~of ~~Secretary~~$0.80/share offor ~~the~~a ~~Company~~total of $1,600,000.

~~Amended~~There were 7,829,047 and ~~Restated~~5,829,047 shares ~~Articles~~of common stock issued and outstanding as of ~~Incorporation~~January 31, 2026, and April 30, 2025, respectively.

NOTE 6 – AMENDED AND RESTATED ARTICLES OF INCORPORATION

On January 13, 2026, the Company filed with the State of Wyoming an Articles of Amendment to its Articles of Incorporation in the form an Amended and Restated Articles of Incorporation (the “Amended and Restated Articles”). The following provisions were included in the Amended and Restated Articles:

Capital Stock. 500,000,000 shares of $.0001 par value common stock are now authorized; 1,000,000 shares of $.0001 par value preferred stock are now authorized. Notwithstanding the designation of the class of Series X Preferred Stock designated in the Amended and Restated Articles (see Item __ below), the designations, preferences, limitations, restrictions, and relative rights of any additional classes of preferred stock, and variations in the relative rights and preferences as between different series, shall be established by the Company’s Board of Directors.

Cumulative Voting. Cumulative voting for the election of directors shall not be permitted.

1.	Capital Stock. 500,000,000 shares of $.001 par value common stock are now authorized; 1,000,000 shares of $.001 par value preferred stock are now authorized. Notwithstanding the designation of the class of Series X Preferred Stock designated in the Amended and Restated Articles, the designations, preferences, limitations, restrictions, and relative rights of any additional classes of preferred stock, and variations in the relative rights and preferences as between different series, shall be established by the Company’s Board of Directors.

2.	Cumulative Voting. Cumulative voting for the election of directors shall not be permitted.

3.	Preemptive Rights. No holder of any stock of the Company shall be entitled, as a matter of right, to purchase, subscribe for or otherwise acquire any new or additional shares of stock of the Company of any class, or any options or warrants to purchase, subscribe for or otherwise acquire any such new or additional shares, or any shares, bonds, notes, debentures or other securities convertible into or carrying options or warrants to purchase, subscribe for or otherwise acquire any such new or additional shares unless specifically authorized by the Board of Directors of the Company.

3. Preemptive Rights. No holder of any stock of the Company shall be entitled, as a matter of right, to purchase, subscribe for or otherwise acquire any new or additional shares of stock of the Company of any class, or any options or warrants to purchase, subscribe for or otherwise acquire any such new or additional shares, or any shares, bonds, notes, debentures or other securities convertible into or carrying options or warrants to purchase, subscribe for or otherwise acquire any such new or additional shares unless specifically authorized by the Board of Directors of the Company. 4. Shareholder Voting on Corporate Actions. Notwithstanding the requirements of Wyoming law, the affirmative vote or concurrence of the holders of a majority of the outstanding shares of the Company entitled to vote thereon are required to make effective all transactions that require shareholder approval under applicable law. 5. Indemnification of Directors, Officers, Employees, Fiduciaries and Agents.

4.	Shareholder Voting on Corporate Actions. Notwithstanding the requirements of Wyoming law, the affirmative vote or concurrence of the holders of a majority of the outstanding shares of the Company entitled to vote thereon are required to make effective all transactions that require shareholder approval under applicable law.

5.	Indemnification of Directors, Officers, Employees, Fiduciaries and Agents.

A. Liability for Monetary Damages. The liability of the directors of the Company for monetary damages shall be eliminated to the fullest extent permissible under Wyoming law provided, however, that (1) the liability of directors is not limited or eliminated (a) for acts or omissions that involve intentional misconduct or a knowing and culpable violation of law, (b) for acts or omissions that a director believes to be contrary to the best interests of the corporation or its shareholders or that involve the absence of good faith on the part of the director, (c) for any transaction from which a director derived an improper personal benefit, (d) for acts or omissions that show a reckless disregard for the director’s duty to the corporation or its shareholders in circumstances in which the director was aware, or should have been aware, in the ordinary course of performing a director’s duties, of a risk of serious injury to the corporation or its shareholders, (e) for acts or omissions that constitute an unexcused pattern of inattention that amounts to an abdication of the director’s duty to the corporation or its shareholders, (2) the liability of directors is not limited or eliminated for any act or omission occurring prior to the date when these Articles of Incorporation becomes effective, or (f) any of the acts set forth in Section 17-16-202 of the Wyoming Business Corporations Act and (3) the liability of officers is not limited or eliminated for any act or omission as an officer, notwithstanding that the officer is also a director or that his or her actions, if negligent or improper, have been ratified by the directors. The Company shall indemnify, to the fullest extent permitted by applicable law, any person, and the estate and personal representative of any such person, against all liability and expense (including attorneys’ fees) incurred by reason of the fact that he is or was a director or officer of the Company or, while serving at the request of the Company as a director, officer, partner, trustee, employee, fiduciary, or agent of, or in any similar managerial or fiduciary position of, another domestic or foreign corporation or other individual or entity or of an employee benefit plan. The Company also shall indemnify any person who is serving or has served the Corporation as director, officer, employee, fiduciary, or agent, and that person’s estate and personal representative, to the extent and in the manner provided in any bylaw, resolution of the shareholders or directors, contract, or otherwise, so long as such provision is legally permissible. B. Expenses. The Company shall advance expenses in advance of the final disposition of the case to or for the benefit of a director, officer, employee, fiduciary, or agent, who is party to a proceeding such as described in the preceding paragraph A to the maximum extent permitted by applicable law. C. Repeal or Modification. Any repeal or modification of the foregoing paragraph by the shareholders of the Company shall not adversely affect any right or protection of a director or officer of the Company or other person entitled to indemnification existing at the time of such repeal or modification.

The Company shall indemnify, to the fullest extent permitted by applicable law, any person, and the estate and personal representative of any such person, against all liability and expense (including attorneys’ fees) incurred by reason of the fact that he is or was a director or officer of the Company or, while serving at the request of the Company as a director, officer, partner, trustee, employee, fiduciary, or agent of, or in any similar managerial or fiduciary position of, another domestic or foreign corporation or other individual or entity or of an employee benefit plan. The Company also shall indemnify any person who is serving or has served the Corporation as director, officer, employee, fiduciary, or agent, and that person’s estate and personal representative, to the extent and in the manner provided in any bylaw, resolution of the shareholders or directors, contract, or otherwise, so long as such provision is legally permissible.

B. Expenses. The Company shall advance expenses in advance of the final disposition of the case to or for the benefit of a director, officer, employee, fiduciary, or agent, who is party to a proceeding such as described in the preceding paragraph A to the maximum extent permitted by applicable law. C. Repeal or Modification. Any repeal or modification of the foregoing paragraph by the shareholders of the Company shall not adversely affect any right or protection of a director or officer of the Company or other person entitled to indemnification existing at the time of such repeal or modification.

Limitations of Liability.

	A.	Limitation of Liability. Notwithstanding Wyoming law, specifically Section 17-16-202 of the Wyoming Business Corporations Act, or the provisions of these Articles of Incorporation, a director of the Company shall not be personally liable to the Company or its shareholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director’s duty of loyalty to the Company or to its shareholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, or (iii) for any transaction from which the director derived an improper personal benefit. If the Wyoming Business Corporations Act is amended after this Article is adopted to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Company shall be eliminated or limited to the fullest extent permitted by the Wyoming Business Corporations Act, as so amended.
	B.	Repeal or Modification. Any repeal or modification of the foregoing paragraph by the shareholders of the Company shall not adversely affect any right or protection of a director of the Company existing at the time of such repeal or modification.

Limitation of Liability. Notwithstanding Wyoming law, specifically Section 17-16-202 of the Wyoming Business Corporations Act, or the provisions of these Articles of Incorporation, a director of the Company shall not be personally liable to the Company or its shareholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director’s duty of loyalty to the Company or to its shareholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, or (iii) for any transaction from which the director derived an improper personal benefit. If the Wyoming Business Corporations Act is amended after this Article is adopted to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Company shall be eliminated or limited to the fullest extent permitted by the Wyoming Business Corporations Act, as so amended.

7. Designation of Series X Preferred Stock. One (1) share of the Company’s authorized shares of Preferred Stock, $0.0001 par value per share, is hereby designated as “Series X Preferred Stock” and having the characteristics set forth below.13

Repeal or Modification. Any repeal or modification of the foregoing paragraph by the shareholders of the Company shall not adversely affect any right or protection of a director of the Company existing at the time of such repeal or modification.

7.	Designation of Series X Preferred Stock. One (1) share of the Company’s authorized shares of Preferred Stock, $0.001 par value per share, is hereby designated as “Series X Preferred Stock” and having the characteristics set forth below.

	A.	Fractional Shares. The Series X Preferred Stock may not be issued in fractional shares.

	B.	Voting. The share of Series X Preferred Stock shall have rights in all matters requiring stockholder approval to a number of votes equal to two (2) times the sum of:

	(1)	The total number of shares of Common Stock which are issued and outstanding at the time of any election or vote by the stockholders; plus

	(2)	The number of votes allocated to shares of Preferred Stock issued and outstanding of any other class that shall have voting rights.

	C.	Conversion. The Series X Preferred Stock shall possess no rights of conversion.

	D.	Liquidation Rights. The Series X Preferred Stock shall possess no liquidation rights.

	E.	Dividends. The Series X Preferred Stock shall possess no dividend rights.

	F.	Protection Provisions. The Company shall not, without first obtaining the consent of the holder of the share of Series X Preferred Stock, alter or change the rights, preferences or privileges of the Series X Preferred Stock so as to affect adversely the holder of the share of Series X Preferred Stock.

	G.	Waiver. Any of the rights, powers or preferences of the Series X Preferred Stock may be waived by the affirmative consent of the holder of the share of Series X Preferred Stock.

	H.	No Other Rights or Privileges. Except as specifically set forth herein, the holder of the share of Series X Preferred Stock shall have no other rights, privileges or preferences with respect to the Series X Preferred Stock.

Conflicting Interest Transactions. No contract or other transaction between the Company and one (1) or more of its directors or any other corporation, firm, association, or entity in which one (1) or more of its directors are directors or officers or are financially interested shall be either void or voided solely because of such relationship or interest, or solely because such directors are present at the meeting of the board of directors or a committee thereof which authorizes, approves, or ratifies such contract or transaction, or solely because their votes are counted for such purpose if:

	A.	The fact of such a relationship or interest is disclosed or known to the Board of Directors or committee that authorizes, approves or ratifies the contract or transaction by a vote or consent sufficient for the purpose without counting the votes or consents of such interested directors;

	B.	The fact of such relationship or interest is disclosed or known to the shareholders entitled to vote and they authorize, approve, or ratify such contract or transaction by vote or written consent; or

	C.	The contract or transaction is fair and reasonable to the Company. Common or interested directors may be counted in determining the presence of a quorum, as herein previously defined, at a meeting of the Board of Directors or a committee thereof that authorizes, approves, or ratifies such contract or transaction.

~~Issuance of Preferred Stock~~14

InNOTE ~~January~~– ~~2026, the Company issued one (1) share of its Series X Preferred Stock (the~~7 ~~“Series~~COMMITMENTS XAND Share”) to Harpreet Sangha, its sole officer and director and holder of the majority voting power. While Mr. Sangha held the majority voting power of the Company prior to such issuance, the Board of Directors of the Company deemed it to be in the best interests of the Company and its shareholders to assure stability and continuity during the Company’s initial stages of development to issue the Series X Share to Mr. Sangha.CONTINGENCIES

~~Property~~During ~~Acquisition~~the ~~Agreement~~normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with Financial Accounting Standards Board (“FASB”) ASC 450-20-50, “Contingencies”. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. As of October 31, 2025, the Company is not aware of any contingent liabilities that should be reflected in the consolidated financial statements.

InNOTE ~~January~~8 ~~2026,~~– ~~the~~CHANGES ~~Company~~IN entered into a purchase agreement (the “Purchase Agreement”) relating to certain mineral rights in and to 21 parcels of real property located in Hardin County, Illinois, and three unpatented lode mining claims located in Mohave County, Arizona (collectively, the “Properties”). The purchase price for the Properties is $300,000 in cash and 2,000,000 shares of common stock of the Company, to be issued within six months of the closing date at a deemed price of $5.00 per share. The cash portion of the Purchase Price is payable, as follows: (a) $25,000 within 30 days of closing; $25,000 within 90 days of closing; $25,000 within 120 days of closing; $125,000 on the first anniversary of closing date; and $100,000 on the second anniversary of closing date. In addition, under the Purchase Agreement, the seller of the Properties retains a 2% net smelter return royalty on any commodities produced from the Properties or from the Area of Interest (defined as the area contained by the outer boundaries of the Properties) by the Company or an affiliate of the Company.CONTROL

December 24, 2025. Effective December 24, 2025, there occurred a change in control of the Company. On such date, Harpreet Sangha acquired 4,500,000 shares of the Company’s common stock from the Company’s former control person, Wang Gang, and was appointed the Sole Officer and Director of the Company.

June 4, 2025. Effective June 4, 2025, there occurred a change in control of the Company. On such date, Wang Gang acquired 4,500,000 shares of the Company’s common stock from the Company’s former control person, Oleg Bilinski, and was appointed the Sole Officer and Director of the Company.

NOTE 9 – PROPERTY ACQUISITION

In January 2026, the Company entered into a purchase agreement (the “Purchase Agreement”) relating to certain mineral rights in and to 21 parcels of real property located in Hardin County, Illinois, and three unpatented lode mining claims located in Mohave County, Arizona (collectively, the “Properties”). The purchase price for the Properties is $300,000 in cash and 2,000,000 shares of common stock of the Company. The cash portion of the Purchase Price is payable, as follows: (a) $25,000 within 30 days of closing; $25,000 within 90 days of closing; $25,000 within 120 days of closing; $125,000 on the first anniversary of closing date; and $100,000 on the second anniversary of closing date. In addition, under the Purchase Agreement, the seller of the Properties retains a 2% net smelter return royalty on any commodities produced from the Properties or from the Area of Interest (defined as the area contained by the outer boundaries of the Properties) by the Company or an affiliate of the Company.

Under the Purchase Agreement, the Company is required to actively explore the Properties with a view to determining their mineral potential and the prospects for their development and future production. Minimum work requirements of the Company are $100,000 and $200,000 for 2026 and 2027, respectively.

NOTE 10 – SUBSEQUENT EVENTS

In accordance with ASC 855, “Subsequent Events”, the Company has analyzed its operations subsequent to October 31, 2025, and has determined that it does not have any material subsequent events to disclose in these financial statements other than the event listed below.

Registration Statement on Form 8-A

On February 6, 2026, the Company filed a Registration on Form 8-A, thereby registering its common stock under the Securities Exchange Act of 1934.

2026 Stock Incentive Plan

In February 2026, the Board of Directors of the Company adopted the 2026 Mag Magna Corp. Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the success and enhance the value of the Company by linking the personal interests of participants (Company employees, Directors and consultants) to those of the Company’s shareholders, and by providing Participants with an incentive for outstanding performance. The Plan is further intended to attract and retain the services of participants upon whose judgment, interest and special efforts the successful operation of the Company and its subsidiaries is dependent. The number of shares of Company common stock available for grant under the Plan is 10,000,000 shares.

Registration Statement on Form S-8

In February 2026, the Company filed a Registration Statement on Form S-8 (SEC File No. 333-293453) (the “S-8 Registration Statement”) with respect to the 10,000,000 shares of Company common stock available for grant under the Plan.

Consulting Agreements

Since January 31, 2026, the Company has issued a total of 7,300,000 shares of common stock to 12 third-party consultants under separate consulting agreements (the “Consulting Agreements”), pursuant to the Plan and pursuant to the S-8 Registration Statement.

Issuance of Common Stock

Since January 31, 2026, the Company has issued a total of 7,300,000 shares of common stock to 12 third-party consultants. 6,000,000 of such shares were valued at $0.10 per share, or $600,000, in the aggregate; 1,300,000 of such shares were valued at $0.077 per share, or $100,000, in the aggregate.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

Statements made in this Form 10-Q that are not historical or current facts are "forward-looking statements" made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 (the "Act") and Section 21E of the Securities Exchange Act of 1934. These statements often can be identified by the use of terms such as “may,” "will," "expect," "believe," "anticipate," "estimate," "approximate" or "continue," or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management’s best judgment as to what April occurs in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

Cautionary Statement

The following discussion and analysis should be read in conjunction with our unaudited financial statements and related notes appearing elsewhere herein.

Our actual results may differ materially from those anticipated in the following discussion, as a result of a variety of risks and uncertainties, including those described under Forward-Looking Statements. We assume no obligation to update any of the forward-looking statements included herein.

Background

The Company was incorporated under the laws of the State of Wyoming on September 20, 2021 (Incorporation). Until January 2026, the Company's primary focus lies in assisting and consulting businesses engaged in poultry farming.

The discussion below relates to the Company’s operating results and financial position prior to the December 2025 change in control and January 2026 determination to change the Company’s plan of business. It is expected that future operating results of the Company will be significantly different than its historical operating results.

1617

~~RESULTS~~Results OFof ~~OPERATIONS~~Operations

~~Three~~Nine ~~months~~Months ~~ended~~Ended ~~October~~ January 31, ~~2025~~2026 ~~compared to~~(“Interim ~~October~~2026”), and January 31, ~~2024~~2025 (“Interim 2025”).

Revenues. During Interim 2026, the Company generated no revenues, compared to revenues of $23,726 (unaudited) during Interim 2025. The revenues generated during Interim 2025 were derived from the Company’s now-abandoned plan of business.

Operating Expenses. During ~~the~~Interim ~~six months ended October 31~~2026, ~~2025~~the ~~and 2024,~~Company weincurred ~~have~~operating ~~generated~~expenses ~~total revenue~~ of $0228,839 ~~and $16~~(unaudited),~~041,~~ ~~respectively.~~compared ~~For~~to ~~the~~operating ~~three~~expenses ~~months~~of ~~ended October 31~~$73,360 ~~2024, the revenue was received~~(unaudited) ~~from~~for ~~the~~Interim ~~sale of consulting services and API requests~~2025.

~~The~~Other ~~reason~~Income. During ~~for~~Interim 2026, the ~~decrease~~Company inhad ~~sales~~not ~~for~~items ~~the~~of ~~three months~~other ~~ended~~income ~~October~~or 31other expense, ~~2025~~ compared to ~~the~~$2 ~~three~~(unaudited) ~~months~~in ~~ended~~other ~~April~~income ~~30,~~for Interim 2025 ~~was that the company has been sold~~.

~~Operating~~Net ~~Expenses~~Loss. During Interim 2026, the Company incurred a net loss of $228,839 (unaudited), compared to a net loss of $29,730 (unaudited) for Interim 2025.

Total operating expenses for the three months ended October 31, 2025 were $7,288 compared to $19,321 for the three months ended October 31, 2024. Expenses in the three months ended October 31, 2025 are accumulated deficit.

Other Income (Expenses)

Total other income for the three months ended October 31, 2025 and 2024 was $Nil and $2, respectively. The other income included interest income.

Net Losses

The net loss for the three months ended October 31, 2025, was $7,288, compared to $14,026 for the three months ended October 31, 2024, due to the factors discussed above.

Liquidity and Capital Resources

As of ~~October~~January 31, ~~2025~~2026, ~~our~~the Company ~~total~~had ~~assets were~~ $~~113~~26,~~090,~~400 ~~which~~(unaudited) ~~comprised~~in ofcash, ~~prepaid~~$499,502 ~~expenses~~(unaudited) ofin ~~$9,345,~~current liabilities and ~~intangible~~a ~~assets~~working capital deficit of $~~102~~475,~~745~~137 (unaudited). As ~~Our~~of ~~total~~April ~~liabilities~~30, ~~were $157~~2025,~~102,~~ ~~which comprised~~the ~~accounts~~Company ~~payable~~had ofno cash, $5227,~~668,~~927 ~~deferred~~in ~~income~~current ofliabilities ~~$NIL~~ and a ~~Loan~~working ~~Payable~~capital ~~due~~deficit ~~to our director~~ of $~~151~~201,~~434.~~620

As of April 30, 2025, our total assets were $144,297, which were comprised of prepaid expenses of $25,975 and intangible assets of $118,322. Our total liabilities at April 30, 2025, were $227,595, which were comprised of accounts payable of $396, deferred income of $5,292 and related party loans payable of $221,927.

The Company had an accumulated deficit of $218,738 as of October 31, 2025, compared to an accumulated deficit of $121,024 as of April 30, 2025, with further losses being anticipated in the development of its business for the foreseeable future.

Cash Flows

During Interim 2026, the Company used $ ~~151~~84,~~577~~542 (unaudited) of cash in operating activities, ~~due~~compared ~~primarily~~ to ~~its net loss of~~ $9731,~~714~~218 ~~and~~(unaudited) ~~change~~of ~~in prepaid expense and amortization expense. We had no~~ cash ~~flows~~ used in oroperating ~~provided by investing~~ activities ~~during Interim 2026. Net cash flows provided by financing activities~~ ~~during~~for Interim ~~2026 were $137,000 from net advances on related party loans~~2025.

17During Interim 2026, $110,942 (unaudited) of cash was provided by financing activities, compared to $31,218 (unaudited) of cash provided in financing activities for Interim 2025.

During Interim 2025, the Company used $562 of cash in operating activities. We had no cash flows used in or provided by investing activities during Interim 2025. Net cash flows provided by financing activities for Interim 2025 were $562.

Off-Balance Sheet Arrangements

WeAt ~~have~~January no30, ~~off-balance~~2026, ~~sheet~~and ~~arrangements including~~at ~~arrangements~~April ~~that would affect our liquidity~~30, ~~capital resources~~2025, ~~market~~the ~~risk~~Company ~~support,~~had ~~and~~no ~~credit~~off-balance ~~risk~~sheet ~~support, or other benefits~~arrangements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not applicable to smaller reporting companies.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

The Company is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

An assessment was conducted with the participation of our principal executive and principal financial officer of the effectiveness of the design and operation of our disclosure controls and procedures as of October 31, 2025. Based on that evaluation, our management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms.

Changes in Internal Controls Over Financial Reporting

There has been no change in our internal control over financial reporting that occurred during the three months ended ~~October~~January 31, ~~2025~~2026, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

1819

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

We know of no legal proceedings to which we are a party or to which any of our property is the subject which are pending, threatened or contemplated or any unsatisfied judgments against us.

Item 1A. Risk Factors.

Not applicable to smaller reporting companies.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Not Applicable.

Item 3. Defaults Upon Senior Securities.

Not Applicable.

Item 4. Mine Safety Disclosures.

Not Applicable.

Item 5. Other Information.

Securities Trading Plans of Directors and Executive Officers

The Company’s ~~sole director~~Board ~~and~~of ~~officer~~Directors ~~has~~did not ~~adopted~~adopt or ~~terminated~~terminate a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (as such terms are defined in Item 408(c) of Regulation S-K), during the three months ended ~~October~~January 31, ~~2025~~2026.

1920

Item 6. Exhibits.

Exhibit No.		Description
31.1*		Certification of Chief Executive Officer ~~and Chief Financial Officer~~ pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).
32.1*		Certifications pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.
31.2*		Certification of Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).
32.1*		Certification of Chief Executive Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.
32.2*		Certification of Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.
101.INS**		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH**		Inline XBRL Taxonomy Extension Schema Document.
101.CAL**		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF**		Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB**		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE**		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104**		Cover Page Interactive Data File (embedded within the Inline XBRL document).

_____________

*	Filed herewith.

**	Furnished and not filed.

2021

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MAG MAGNA CORP.
Date: January 27, 2026	By:	/s/ Harpreet Sangha
Date: March 26, 2026	By:	/s/ Jamal Khurshid
		Harpreet Sangha, Chief Executive Officer/Director
		Jamal Khurshid, Chief Executive Officer
		(Principle Executive Officer), Chief Financial Officer/Chief Accounting Officer/Director (Principle Financial Officer)

2122

Filing Compare · Mag Magna Corp